| Nitrosative stress drives heart failure with preserved ejection fraction GG Schiattarella, F Altamirano, D Tong, KM French, E Villalobos, SY Kim, ... Nature 568 (7752), 351-356, 2019 | 728 | 2019 |
| Cancer therapy–induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies VS Hahn, DJ Lenihan, B Ky Journal of the American Heart Association 3 (2), e000665, 2014 | 302 | 2014 |
| Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis VS Hahn, LR Yanek, J Vaishnav, W Ying, D Vaidya, YZJ Lee, SJ Riley, ... Heart failure 8 (9), 712-724, 2020 | 228 | 2020 |
| Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy K Seo, PP Rainer, V Shalkey Hahn, D Lee, SH Jo, A Andersen, T Liu, ... Proceedings of the National Academy of Sciences 111 (4), 1551-1556, 2014 | 220 | 2014 |
| Myocardial gene expression signatures in human heart failure with preserved ejection fraction VS Hahn, H Knutsdottir, X Luo, K Bedi, KB Margulies, SM Haldar, ... Circulation 143 (2), 120-134, 2021 | 208 | 2021 |
| Longitudinal changes in multiple biomarkers are associated with cardiotoxicity in breast cancer patients treated with doxorubicin, taxanes, and trastuzumab M Putt, VS Hahn, JL Januzzi, H Sawaya, IA Sebag, JC Plana, MH Picard, ... Clinical chemistry 61 (9), 1164-1172, 2015 | 188 | 2015 |
| Myocardial metabolomics of human heart failure with preserved ejection fraction VS Hahn, C Petucci, MS Kim, KC Bedi Jr, H Wang, S Mishra, N Koleini, ... Circulation 147 (15), 1147-1161, 2023 | 113 | 2023 |
| Prevention of PKG1α oxidation augments cardioprotection in the stressed heart T Nakamura, MJ Ranek, DI Lee, VS Hahn, C Kim, P Eaton, DA Kass The Journal of clinical investigation 125 (6), 2468-2472, 2015 | 85 | 2015 |
| Osteopontin promotes left ventricular diastolic dysfunction through a mitochondrial pathway K Yousefi, CI Irion, LM Takeuchi, W Ding, G Lambert, T Eisenberg, ... Journal of the American College of Cardiology 73 (21), 2705-2718, 2019 | 52 | 2019 |
| Heart failure with targeted cancer therapies: mechanisms and cardioprotection VS Hahn, KW Zhang, L Sun, V Narayan, DJ Lenihan, B Ky Circulation research 128 (10), 1576-1593, 2021 | 48 | 2021 |
| Reduced right ventricular sarcomere contractility in heart failure with preserved ejection fraction and severe obesity MI Aslam, VS Hahn, V Jani, S Hsu, K Sharma, DA Kass Circulation 143 (9), 965-967, 2021 | 46 | 2021 |
| Leveraging signaling pathways to treat heart failure with reduced ejection fraction: past, present, and future M Pinilla-Vera, VS Hahn, DA Kass Circulation research 124 (11), 1618-1632, 2019 | 44 | 2019 |
| CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury MJ Ranek, C Oeing, R Sanchez-Hodge, KM Kokkonen-Simon, D Dillard, ... Nature communications 11 (1), 5237, 2020 | 41 | 2020 |
| Tetrahydrobiopterin protects against hypertrophic heart disease independent of myocardial nitric oxide synthase coupling T Hashimoto, V Sivakumaran, R Carnicer, G Zhu, VS Hahn, D Bedja, ... Journal of the American Heart Association 5 (3), e003208, 2016 | 27 | 2016 |
| Acute hemodynamic effects and tolerability of phosphodiesterase-1 inhibition with ITI-214 in human systolic heart failure NA Gilotra, AD DeVore, TJ Povsic, AG Hays, VS Hahn, TA Agunbiade, ... Circulation: Heart Failure 14 (9), e008236, 2021 | 23 | 2021 |
| A report of accelerated coronary artery disease associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy CB Rubin, V Hahn, T Kobayashi, A Litwack Case Reports in Cardiology 2015 (1), 167513, 2015 | 14 | 2015 |
| Under-enrollment of obese heart failure with preserved ejection fraction patients in major HFpEF clinical trials J Vaishnav, LR Yanek, VS Hahn, E Yang, R Trivedi, DA Kass, K Sharma Journal of cardiac failure 28 (5), 723-731, 2022 | 9 | 2022 |
| Landscape of glycolytic metabolites and their regulating proteins in myocardium from human heart failure with preserved ejection fraction N Koleini, M Meddeb, L Zhao, M Keykhaei, S Kwon, F Farshidfar, ... European Journal of Heart Failure 26 (9), 1941-1951, 2024 | 8 | 2024 |
| Cardiac and hemodynamic effects of acute phosphodiesterase-1 inhibition in human heart failure NA Gilotra, A Devore, A Hays, V Hahn, TA Agunbiade, R Chen, R Davis, ... Journal of Cardiac Failure 26 (10), S12, 2020 | 6 | 2020 |
| Myocardial ultrastructure of human heart failure with preserved ejection fraction M Meddeb, N Koleini, A Binek, M Keykhaei, R Darehgazani, S Kwon, ... Nature Cardiovascular Research 3 (8), 907-914, 2024 | 5 | 2024 |
